EMEA-001567-PIP01-13-M03

Key facts

Active substance
naloxone (hydrochloride)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0146/2018
PIP number
EMEA-001567-PIP01-13-M03
Pharmaceutical form(s)
  • Prolonged-release tablet
  • Age-appropriate prolonged-release oral formulation
Condition(s) / indication(s)
Treatment of opioid-induced constipation
Route(s) of administration
Oral use
Contact for public enquiries
Develco Pharma GmbH

E-mail: n.burger@develco.ch
Tel.  +41 6142 55020

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating